• News
  • Finance

Daily Digest

Acadia Pharmaceuticals Inc. announced it is hosting a conference call and webcast to discuss its top-line results from its Phase III trial with pimavanserin in patients with Parkinson’s disease psychosis, and Inovio Pharmaceuticals Inc. announced that testing of multiple synthetic vaccine constructs for cytomegalovirus induced robust T cells in mice, according to company announcements, SEC filings and Bloomberg News.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!